A detailed history of Us Bancorp \De\ transactions in Biogen Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 20,214 shares of BIIB stock, worth $3.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,214
Previous 23,969 15.67%
Holding current value
$3.15 Million
Previous $5.56 Million 29.48%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$189.07 - $236.8 $709,957 - $889,184
-3,755 Reduced 15.67%
20,214 $3.92 Million
Q2 2024

Aug 06, 2024

BUY
$190.52 - $236.72 $1.22 Million - $1.51 Million
6,393 Added 36.37%
23,969 $5.56 Million
Q1 2024

May 07, 2024

SELL
$212.02 - $267.71 $561,428 - $708,896
-2,648 Reduced 13.09%
17,576 $3.79 Million
Q4 2023

Feb 09, 2024

SELL
$222.59 - $267.94 $151,361 - $182,199
-680 Reduced 3.25%
20,224 $5.23 Million
Q3 2023

Nov 03, 2023

SELL
$253.3 - $285.89 $628,184 - $709,007
-2,480 Reduced 10.61%
20,904 $5.37 Million
Q2 2023

Aug 09, 2023

SELL
$275.25 - $318.06 $245,798 - $284,027
-893 Reduced 3.68%
23,384 $6.66 Million
Q1 2023

May 09, 2023

SELL
$256.56 - $292.34 $449,749 - $512,472
-1,753 Reduced 6.73%
24,277 $6.75 Million
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $439,750 - $534,306
1,742 Added 7.17%
26,030 $7.21 Million
Q3 2022

Oct 27, 2022

SELL
$194.69 - $268.46 $427,733 - $589,806
-2,197 Reduced 8.3%
24,288 $6.48 Million
Q2 2022

Aug 01, 2022

SELL
$187.54 - $223.02 $702,524 - $835,432
-3,746 Reduced 12.39%
26,485 $5.4 Million
Q1 2022

May 11, 2022

SELL
$193.77 - $244.14 $1.16 Million - $1.47 Million
-6,006 Reduced 16.57%
30,231 $6.37 Million
Q4 2021

Feb 11, 2022

SELL
$223.92 - $287.77 $2.15 Million - $2.76 Million
-9,593 Reduced 20.93%
36,237 $8.7 Million
Q3 2021

Nov 10, 2021

SELL
$282.99 - $369.05 $632,199 - $824,457
-2,234 Reduced 4.65%
45,830 $13 Million
Q2 2021

Aug 05, 2021

SELL
$259.0 - $414.71 $2.74 Million - $4.38 Million
-10,560 Reduced 18.01%
48,064 $16.6 Million
Q1 2021

Apr 28, 2021

SELL
$242.95 - $284.63 $391,635 - $458,823
-1,612 Reduced 2.68%
58,624 $16.4 Million
Q4 2020

Feb 04, 2021

SELL
$236.26 - $355.63 $1.49 Million - $2.25 Million
-6,325 Reduced 9.5%
60,236 $14.7 Million
Q3 2020

Nov 10, 2020

SELL
$264.77 - $305.71 $1.32 Million - $1.53 Million
-5,004 Reduced 6.99%
66,561 $18.9 Million
Q2 2020

Aug 07, 2020

SELL
$258.66 - $342.55 $927,813 - $1.23 Million
-3,587 Reduced 4.77%
71,565 $19.1 Million
Q1 2020

May 13, 2020

SELL
$268.85 - $341.04 $3.83 Million - $4.85 Million
-14,230 Reduced 15.92%
75,152 $23.8 Million
Q4 2019

Feb 04, 2020

SELL
$220.06 - $304.07 $5.89 Million - $8.14 Million
-26,786 Reduced 23.06%
89,382 $26.5 Million
Q3 2019

Nov 08, 2019

SELL
$217.44 - $243.88 $2.33 Million - $2.61 Million
-10,700 Reduced 8.43%
116,168 $27 Million
Q2 2019

Aug 13, 2019

SELL
$219.29 - $241.72 $7.66 Million - $8.44 Million
-34,914 Reduced 21.58%
126,868 $29.7 Million
Q1 2019

May 08, 2019

SELL
$216.71 - $338.96 $195,689 - $306,080
-903 Reduced 0.56%
161,782 $38.2 Million
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $1.83 Million - $2.32 Million
6,571 Added 4.21%
162,685 $49 Million
Q3 2018

Nov 01, 2018

SELL
$293.51 - $383.83 $3.13 Million - $4.09 Million
-10,651 Reduced 6.39%
156,114 $55.2 Million
Q2 2018

Aug 08, 2018

BUY
$257.52 - $306.91 $377,009 - $449,316
1,464 Added 0.89%
166,765 $48.4 Million
Q1 2018

May 08, 2018

BUY
$260.13 - $367.91 $2.62 Million - $3.7 Million
10,057 Added 6.48%
165,301 $45.3 Million
Q4 2017

Feb 02, 2018

BUY
$307.64 - $344.58 $1.45 Million - $1.62 Million
4,706 Added 3.13%
155,244 $49.5 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $42.3 Million - $49.6 Million
150,538
150,538 $47.1 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.